Catalyst is Lila's platform-access offering, giving partner teams direct use of Lila Iris and AI Science Factories alongside scientific experts to design, run, and interpret more experiments in less time. It turns existing research programs into faster, higher-confidence discovery engines.
Through a lab-as-a-service model, Catalyst converts fixed lab capacity and capital expenditure into an on-demand resource, expanding experimental throughput and reducing cycle times. Internal scientists can focus on strategy, design decisions, and downstream development rather than running and maintaining complex lab workflows.

Catalyst gives partner science teams direct platform access to Lila Iris and AI Science Factories.



Pharma.ai is Insilico Medicine's generative AI platform for drug discovery, target identification, and molecule design.


Recursion OS is an AI-powered drug discovery and development platform built on massive proprietary biological and chemical datasets.
PEGASUS is 1910's multimodal AI model for de novo design and lead optimization of cell-permeable macrocyclic peptides.

Pharma.ai is Insilico Medicine's generative AI platform for drug discovery, target identification, and molecule design.

Recursion OS is an AI-powered drug discovery and development platform built on massive proprietary biological and chemical datasets.



AI-native platform that designs, runs, and improves plate-based scientific experiments autonomously.


AI Experimentalist plans scientific experiments and interprets laboratory results within Medra’s closed-loop platform.


Autonomous AI agents that orchestrate and run scientific research workflows.



Physical AI platform that captures scientific lab execution as machine-readable records.


AI platform combining human research with self-improving AI for scientific discovery.


Sapio Lab Informatics Platform unifies LIMS, ELN, and scientific data cloud in one AI-native lab informatics system.



Isomorphic Labs' Drug Design Engine builds on AlphaFold to predict biomolecular structures for drug discovery.


Biology-First AI platform predicts disease-matched compounds using multi-omics human data and functional validation.


1910's ITO™ platform orchestrates multimodal AI and lab automation for small and large molecule drug discovery.


GEMS (Genesis Exploration of Molecular Space) is a generative AI platform for small-molecule drug discovery.


AI-enabled natural-product drug discovery platform organizing plant chemistry into a searchable library with machine-learning translation and automated screening.


A tissue-first platform generating spatial, molecular, and functional maps from patient tumors.
AI-native platform that designs, runs, and improves plate-based scientific experiments autonomously.

AI Experimentalist plans scientific experiments and interprets laboratory results within Medra’s closed-loop platform.

Autonomous AI agents that orchestrate and run scientific research workflows.

Fluidize is an AI-powered scientific computing platform that automates simulation and experiment workflows for R&D teams.

Physical AI platform that captures scientific lab execution as machine-readable records.

AI platform combining human research with self-improving AI for scientific discovery.

Sapio Lab Informatics Platform unifies LIMS, ELN, and scientific data cloud in one AI-native lab informatics system.

Qualia is an AI research agent for notebook-based computational experiments.

Isomorphic Labs' Drug Design Engine builds on AlphaFold to predict biomolecular structures for drug discovery.

Biology-First AI platform predicts disease-matched compounds using multi-omics human data and functional validation.

1910's ITO™ platform orchestrates multimodal AI and lab automation for small and large molecule drug discovery.

GEMS (Genesis Exploration of Molecular Space) is a generative AI platform for small-molecule drug discovery.

AI-enabled natural-product drug discovery platform organizing plant chemistry into a searchable library with machine-learning translation and automated screening.

A tissue-first platform generating spatial, molecular, and functional maps from patient tumors.
